A detailed history of Fidelity D & D Bancorp Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Fidelity D & D Bancorp Inc holds 2,361 shares of ABT stock, worth $269,885. This represents 0.18% of its overall portfolio holdings.

Number of Shares
2,361
Holding current value
$269,885
% of portfolio
0.18%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 06, 2024

BUY
$100.07 - $118.13 $236,265 - $278,904
2,361 New
2,361 $269 Million
Q1 2024

Apr 16, 2024

SELL
$109.52 - $120.96 $5,256 - $5,806
-48 Reduced 2.52%
1,860 $211 Million
Q4 2023

Jan 12, 2024

SELL
$90.19 - $110.4 $30,123 - $36,873
-334 Reduced 14.9%
1,908 $210 Million
Q3 2023

Nov 30, 2023

BUY
$95.53 - $114.62 $214,178 - $256,978
2,242 New
2,242 $217 Million
Q1 2023

Apr 16, 2024

SELL
$96.86 - $114.01 $4,649 - $5,472
-48 Reduced 2.52%
1,860 $211 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Fidelity D & D Bancorp Inc Portfolio

Follow Fidelity D & D Bancorp Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fidelity D & D Bancorp Inc, based on Form 13F filings with the SEC.

News

Stay updated on Fidelity D & D Bancorp Inc with notifications on news.